NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying chemical intermediates that are vital for developing advanced therapeutic solutions. Acotiamide is one such compound, recognized for its efficacy in treating functional dyspepsia (FD) by directly addressing issues related to gastric emptying and bloating.

Gastric emptying, the process by which food leaves the stomach, is often impaired in individuals with FD. This delay can lead to a range of uncomfortable symptoms, including prolonged feelings of fullness after eating and significant bloating. Acotiamide, as a potent acetylcholinesterase inhibitor, offers a direct solution by enhancing the gastrointestinal (GI) motility responsible for efficient gastric emptying.

The mechanism of action of Acotiamide involves inhibiting the enzyme acetylcholinesterase. This inhibition leads to an increased concentration of acetylcholine, a neurotransmitter that stimulates the smooth muscles of the GI tract. Consequently, this results in enhanced gastric contractility and accelerated gastric emptying. The improved movement of food through the digestive system is key to reducing bloating and other symptoms associated with FD.

Clinical studies underscore the benefits of Acotiamide for bloating and other dyspeptic complaints. Patients often report a significant reduction in postprandial fullness and a general improvement in overall digestive comfort. By normalizing the rate of gastric emptying, Acotiamide helps to prevent the buildup of undigested food in the stomach, which is a common cause of bloating and discomfort.

For researchers and pharmaceutical developers, sourcing high-quality Acotiamide is crucial. NINGBO INNO PHARMCHEM CO.,LTD. provides Acotiamide with the purity and consistency required for rigorous scientific investigation and drug development. Our commitment to quality ensures that our clients can confidently explore the therapeutic potential of Acotiamide in various gastrointestinal motility disorders.